Orthosiphon stamineus protects Caenorhabditis elegans against Staphylococcus aureus infection through immunomodulation

Biology Open

Volumn 3, Issue 7, 2014, Pages 644-655

  Kong, Cin ^a   Tan, Man Wah ^b,c   Nathan, Sheila ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GENENTECH INC   (United States)

Author keywords

Anti infective; C. elegans; Immunomodulation; O. stamineus; S. aureus

Indexed keywords

EID: 84978481320     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.20148334     Document Type: Article

References (62)

1. Adonizio, A., Leal, S. M., Jr, Ausubel, F. M. and Mathee, K. (2008). Attenuation of Pseudomonas aeruginosa virulence by medicinal plants in a Caenorhabditis elegans model system. J. Med. Microbiol. 57, 809-813.
2. Alper, S., McBride, S. J., Lackford, B., Freedman, J. H. and Schwartz, D. A. (2007). Specificity and complexity of the Caenorhabditis elegans innate immune response. Mol. Cell. Biol. 27, 5544-5553.
3. Alshawsh, M. A., Abdulla, M. A., Ismail, S., Amin, Z. A., Qader, S. W., Hadi, H. A. and Harmal, N. S. (2012). Free radical scavenging, antimicrobial and immunomodulatory activities of Orthosiphon stamineus. Molecules 17, 5385-5395.
4. Ameer, O. Z., Salman, I. M., Asmawi, M. Z., Ibraheem, Z. O. and Yam, M. F. (2012). Orthosiphon stamineus: traditional uses, phytochemistry, pharmacology, and toxicology. J. Med. Food 15, 678-690.
5. Archer, G. L. (1998). Staphylococcus aureus: a well-armed pathogen. Clin. Infect. Dis. 26, 1179-1181.
6. Balaban, N., Cirioni, O., Giacometti, A., Ghiselli, R., Braunstein, J. B., Silvestri, C., Mocchegiani, F., Saba, V. and Scalise, G. (2007). Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob. Agents Chemother. 51, 2226-2229.
7. Breger, J., Fuchs, B. B., Aperis, G., Moy, T. I., Ausubel, F. M. and Mylonakis, E. (2007). Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 3, e18.
8. Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71-94.
9. Cowan, M. M. (1999). Plant products as antimicrobial agents. Clin. Microbiol. Rev. 12, 564-582.
10. Cragg, G. M., Newman, D. J. and Snader, K. M. (1997). Natural products in drug discovery and development. J. Nat. Prod. 60, 52-60.
11. DesJardin, J. A. and Snydman, D. R. (1998). Antiviral immunotherapy: a review of current status. BioDrugs 9, 487-507.
12. Dharmalingam, K., Tan, B. K., Mahmud, M. Z., Sedek, S. A., Majid, M. I., Kuah, M. K., Sulaiman, S. F., Ooi, K. L., Khan, N. A., Muhammad, T. S. et al. (2012). Swietenia macrophylla extract promotes the ability of Caenorhabditis elegans to survive Pseudomonas aeruginosa infection. J. Ethnopharmacol. 139, 657-663.
13. Evans, E. A., Kawli, T. and Tan, M. W. (2008). Pseudomonas aeruginosa suppresses host immunity by activating the DAF-2 insulin-like signaling pathway in Caenorhabditis elegans. PLoS Pathog. 4, e1000175.
14. Garsin, D. A., Sifri, C. D., Mylonakis, E., Qin, X., Singh, K. V., Murray, B. E., Calderwood, S. B. and Ausubel, F. M. (2001). A simple model host for identifying Gram-positive virulence factors. Proc. Natl. Acad. Sci. USA 98, 10892-10897.
15. Garsin, D. A., Villanueva, J. M., Begun, J., Kim, D. H., Sifri, C. D., Calderwood, S. B., Ruvkun, G. and Ausubel, F. M. (2003). Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science 300, 1921.
16. Grundmann, H., Aanensen, D. M., van den Wijngaard, C. C., Spratt, B. G., Harmsen, D. and Friedrich, A. W.; European Staphylococcal Reference Laboratory Working Group (2010). Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med. 7, e1000215.
17. Hancock, R. E., Nijnik, A. and Philpott, D. J. (2012). Modulating immunity as a therapy for bacterial infections. Nat. Rev. Microbiol. 10, 243-254.
18. Ho, C.-H., Noryati, I., Sulaiman, S.-F. and Rosma, A. (2010). In vitro antibacterial and antioxidant activities of Orthosiphon stamineus Benth. extracts against food-borne bacteria. Food Chem. 122, 1168-1172.
19. Irazoqui, J. E., Ng, A., Xavier, R. J. and Ausubel, F. M. (2008). Role for beta-catenin and HOX transcription factors in Caenorhabditis elegans and mammalian host epithelial-pathogen interactions. Proc. Natl. Acad. Sci. USA 105, 17469-17474.
20. Irazoqui, J. E., Troemel, E. R., Feinbaum, R. L., Luhachack, L. G., Cezairliyan, B. O. and Ausubel, F. M. (2010). Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus. PLoS Pathog. 6, e1000982.
21. Jakobsen, H., Bojer, M. S., Marinus, M. G., Xu, T., Struve, C., Krogfelt, K. A. and Løbner-Olesen, A. (2013). The alkaloid compound harmane increases the lifespan of Caenorhabditis elegans during bacterial infection, by modulating the nematode's innate immune response. PLoS ONE 8, e60519.
22. JebaMercy, G., Pandian, S. K. and Balamurugan, K. (2011). Changes in Caenorhabditis elegans life span and selective innate immune genes during Staphylococcus aureus infection. Folia Microbiol. (Praha) 56, 373-380.
23. Kato, Y., Aizawa, T., Hoshino, H., Kawano, K., Nitta, K. and Zhang, H. (2002). abf-1 and abf-2, ASABF-type antimicrobial peptide genes in Caenorhabditis elegans. Biochem. J. 361, 221-230.
24. Keane, J. and Avery, L. (2003). Mechanosensory inputs influence Caenorhabditis elegans pharyngeal activity via ivermectin sensitivity genes. Genetics 164, 153-162.
25. Khodaverdian, V., Pesho, M., Truitt, B., Bollinger, L., Patel, P., Nithianantham, S., Yu, G., Delaney, E., Jankowsky, E. and Shoham, M. (2013). Discovery of antivirulence agents against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 57, 3645-3652.
26. Kim, D. H., Feinbaum, R., Alloing, G., Emerson, F. E., Garsin, D. A., Inoue, H., Tanaka-Hino, M., Hisamoto, N., Matsumoto, K., Tan, M. W. et al. (2002). A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 297, 623-626.
27. Kindrachuk, J., Jenssen, H., Elliott, M., Nijnik, A., Magrangeas-Janot, L., Pasupuleti, M., Thorson, L., Ma, S., Easton, D. M., Bains, M. et al. (2013). Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory. Innate Immun 19, 315-327.
28. Klevens, R. M., Morrison, M. A., Nadle, J., Petit, S., Gershman, K., Ray, S., Harrison, L. H., Lynfield, R., Dumyati, G., Townes, J. M. et al.; Active Bacterial Core surveillance (ABCs) MRSA Investigators (2007). Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298, 1763-1771.
29. Kong, C., Yehye, W. A., Abd Rahman, N., Tan, M. W. and Nathan, S. (2014). Discovery of potential anti-infectives against Staphylococcus aureus using a Caenorhabditis elegans infection model. BMC Complement. Altern. Med. 14, 4.
30. Laavola, M., Nieminen, R., Yam, M. F., Sadikun, A., Asmawi, M. Z., Basir, R., Welling, J., Vapaatalo, H., Korhonen, R. and Moilanen, E. (2012). Flavonoids eupatorin and sinensetin present in Orthosiphon stamineus leaves inhibit inflammatory gene expression and STAT1 activation. Planta Med. 78, 779-786.
31. Lee, S. H., Ooi, S. K., Mahadi, N. M., Tan, M. W. and Nathan, S. (2011). Complete killing of Caenorhabditis elegans by Burkholderia pseudomallei is dependent on prolonged direct association with the viable pathogen. PLoS ONE 6, e16707.
32. Leippe, M. (1999). Antimicrobial and cytolytic polypeptides of amoeboid protozoa - effector molecules of primitive phagocytes. Dev. Comp. Immunol. 23, 267-279.
33. Liu, J., Hafting, J., Critchley, A. T., Banskota, A. H. and Prithiviraj, B. (2013). Components of the cultivated red seaweed Chondrus crispus enhance the immune response of Caenorhabditis elegans to Pseudomonas aeruginosa through the pmk-1, daf-2/daf-16, and skn-1 pathways. Appl. Environ. Microbiol. 79, 7343-7350.
34. Luo, S., Shaw, W. M., Ashraf, J. and Murphy, C. T. (2009). TGF-beta Sma/Mab signaling mutations uncouple reproductive aging from somatic aging. PLoS Genet. 5, e1000789.
35. Mahady, G. B., Huang, Y., Doyle, B. J. and Locklear, T. (2008). Natural products as antibacterial agents. Studies in Natural Products Chemistry 35, 423-444.
36. Mallo, G. V., Kurz, C. L., Couillault, C., Pujol, N., Granjeaud, S., Kohara, Y. and Ewbank, J. J. (2002). Inducible antibacterial defense system in C. elegans. Curr. Biol. 12, 1209-1214.
37. Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K. and Ausubel, F. M. (2006). Identification of novel antimicrobials using a live-animal infection model. Proc. Natl. Acad. Sci. USA 103, 10414-10419.
38. Murphy, C. T., McCarroll, S. A., Bargmann, C. I., Fraser, A., Kamath, R. S., Ahringer, J., Li, H. and Kenyon, C. (2003). Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277-283.
39. Nicholas, H. R. and Hodgkin, J. (2004). Responses to infection and possible recognition strategies in the innate immune system of Caenorhabditis elegans. Mol. Immunol. 41, 479-493.
40. O'Rourke, D., Baban, D., Demidova, M., Mott, R. and Hodgkin, J. (2006). Genomic clusters, putative pathogen recognition molecules, and antimicrobial genes are induced by infection of C. elegans with M. nematophilum. Genome Res. 16, 1005-1016.
41. Olah, N. K., Radu, L., Mogoşan, C., Hanganu, D. and Gocan, S. (2003). Phytochemical and pharmacological studies on Orthosiphon stamineus Benth. (Lamiaceae) hydroalcoholic extracts. J. Pharm. Biomed. Anal. 33, 117-123.
42. Ooi, S. K., Lim, T. Y., Lee, S. H. and Nathan, S. (2012). Burkholderia pseudomallei kills Caenorhabditis elegans through virulence mechanisms distinct from intestinal lumen colonization. Virulence 3, 485-496.
43. Pan, Y., Abd-Rashid, B. A., Ismail, Z., Ismail, R., Mak, J. W., Pook, P. C., Er, H. M. and Ong, C. E. (2011). In vitro effects of active constituents and extracts of Orthosiphon stamineus on the activities of three major human cDNA-expressed cytochrome P450 enzymes. Chem. Biol. Interact. 190, 1-8.
44. Perez, F., Salata, R. A. and Bonomo, R. A. (2008). Current and novel antibiotics against resistant Gram-positive bacteria. Infect Drug Resist 1, 27-44.
45. Pukkila-Worley, R., Feinbaum, R., Kirienko, N. V., Larkins-Ford, J., Conery, A. L. and Ausubel, F. M. (2012). Stimulation of host immune defenses by a small molecule protects C. elegans from bacterial infection. PLoS Genet. 8, e1002733.
46. Roeder, T., Stanisak, M., Gelhaus, C., Bruchhaus, I., Grötzinger, J. and Leippe, M. (2010). Caenopores are antimicrobial peptides in the nematode Caenorhabditis elegans instrumental in nutrition and immunity. Dev. Comp. Immunol. 34, 203-209.
47. Rudrappa, T. and Bais, H. P. (2008). Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. J. Agric. Food Chem. 56, 1955-1962.
48. Schulenburg, H. and Boehnisch, C. (2008). Diversification and adaptive sequence evolution of Caenorhabditis lysozymes (Nematoda: Rhabditidae). BMC Evol. Biol. 8, 114.
49. Schulenburg, H., Hoeppner, M. P., Weiner, J., 3rd and Bornberg-Bauer, E. (2008). Specificity of the innate immune system and diversity of C-type lectin domain (CTLD) proteins in the nematode Caenorhabditis elegans. Immunobiology 213, 237-250.
50. Sifri, C. D., Begun, J., Ausubel, F. M. and Calderwood, S. B. (2003). Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect. Immun. 71, 2208-2217.
51. Sifri, C. D., Begun, J. and Ausubel, F. M. (2005). The worm has turned - microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol. 13, 119-127.
52. Tabara, H., Hill, R. J., Mello, C. C., Priess, J. R. and Kohara, Y. (1999). pos-1 encodes a cytoplasmic zinc-finger protein essential for germline specification in C. elegans. Development 126, 1-11.
53. Tan, M. W., Mahajan-Miklos, S. and Ausubel, F. M. (1999). Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc. Natl. Acad. Sci. USA 96, 715-720.
54. Trnková, K., Pastoreková, S. and Petrik, J. (2012). Novel approaches to antiviral and anticancer immunotherapy. Acta Virol. 56, 271-282.
55. Troemel, E. R., Chu, S. W., Reinke, V., Lee, S. S., Ausubel, F. M. and Kim, D. H. (2006). p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet. 2, e183.
56. Van Voorhies, W. A., Fuchs, J. and Thomas, S. (2005). The longevity of Caenorhabditis elegans in soil. Biol. Lett. 1, 247-249.
57. Waldmann, T. A. (2006). Effective cancer therapy through immunomodulation. Annu. Rev. Med. 57, 65-81.
58. Wu, H., Song, Z., Hentzer, M., Andersen, J. B., Molin, S., Givskov, M. and Høiby, N. (2004). Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J. Antimicrob. Chemother. 53, 1054-1061.
59. Wu, K., Conly, J., McClure, J. A., Elsayed, S., Louie, T. and Zhang, K. (2010). Caenorhabditis elegans as a host model for community-associated methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 16, 245-254.
60. Yam, M. F., Mohamed, E. A., Ang, L. F., Pei, L., Darwis, Y., Mahmud, R., Asmawi, M. Z., Basir, R. and Ahmad, M. (2012). A simple isocratic HPLC method for the simultaneous determination of sinensetin, eupatorin, and 3′-hydroxy-5,6,7,4′-tetramethoxyflavone in Orthosiphon stamineus extracts. J Acupunct Meridian Stud 5, 176-182.
61. Yu, Y. B., Dosanjh, L., Lao, L., Tan, M., Shim, B. S. and Luo, Y. (2010). Cinnamomum cassia bark in two herbal formulas increases life span in Caenorhabditis elegans via insulin signaling and stress response pathways. PLoS ONE 5, e9339.
62. Zheng, S. Q., Ding, A. J., Li, G. P., Wu, G. S. and Luo, H. R. (2013). Drug absorption efficiency in Caenorhbditis elegans delivered by different methods. PLoS ONE 8, e56877.